Acute stroke thrombolysis in infective endocarditis

Intravenous recombinant tissue plasminogen activator is not recommended for the treatment of acute ischemic stroke in patients with infective endocarditis due to the risk of hemorrhagic transformation of septic emboli and few reported cases in the literature. Here, we present the successful outcome...

Descripción completa

Detalles Bibliográficos
Autores principales: Ashkanani, Abdulaziz, Bitar, Zouhair, Maadrani, Osama
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196617/
https://www.ncbi.nlm.nih.gov/pubmed/30364436
http://dx.doi.org/10.1177/2050313X18807629
_version_ 1783364588988792832
author Ashkanani, Abdulaziz
Bitar, Zouhair
Maadrani, Osama
author_facet Ashkanani, Abdulaziz
Bitar, Zouhair
Maadrani, Osama
author_sort Ashkanani, Abdulaziz
collection PubMed
description Intravenous recombinant tissue plasminogen activator is not recommended for the treatment of acute ischemic stroke in patients with infective endocarditis due to the risk of hemorrhagic transformation of septic emboli and few reported cases in the literature. Here, we present the successful outcome of intravenous recombinant tissue plasminogen activator administration for a patient with acute ischemic stroke who was later found to have infective endocarditis. This case adds to the small number of cases reported in the literature.
format Online
Article
Text
id pubmed-6196617
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-61966172018-10-24 Acute stroke thrombolysis in infective endocarditis Ashkanani, Abdulaziz Bitar, Zouhair Maadrani, Osama SAGE Open Med Case Rep Case Report Intravenous recombinant tissue plasminogen activator is not recommended for the treatment of acute ischemic stroke in patients with infective endocarditis due to the risk of hemorrhagic transformation of septic emboli and few reported cases in the literature. Here, we present the successful outcome of intravenous recombinant tissue plasminogen activator administration for a patient with acute ischemic stroke who was later found to have infective endocarditis. This case adds to the small number of cases reported in the literature. SAGE Publications 2018-10-19 /pmc/articles/PMC6196617/ /pubmed/30364436 http://dx.doi.org/10.1177/2050313X18807629 Text en © The Author(s) 2018 http://www.creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Case Report
Ashkanani, Abdulaziz
Bitar, Zouhair
Maadrani, Osama
Acute stroke thrombolysis in infective endocarditis
title Acute stroke thrombolysis in infective endocarditis
title_full Acute stroke thrombolysis in infective endocarditis
title_fullStr Acute stroke thrombolysis in infective endocarditis
title_full_unstemmed Acute stroke thrombolysis in infective endocarditis
title_short Acute stroke thrombolysis in infective endocarditis
title_sort acute stroke thrombolysis in infective endocarditis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196617/
https://www.ncbi.nlm.nih.gov/pubmed/30364436
http://dx.doi.org/10.1177/2050313X18807629
work_keys_str_mv AT ashkananiabdulaziz acutestrokethrombolysisininfectiveendocarditis
AT bitarzouhair acutestrokethrombolysisininfectiveendocarditis
AT maadraniosama acutestrokethrombolysisininfectiveendocarditis

Ejemplares similares